Semaglutide and tirzepatide recommended as first-line treatment of obesity and most of its complications in new guidance from European Association for the Study of Obesity (EASO) Semaglutide and tirzepatide recommended as first-line treatment of obesity and most of its complications in new guidance from European Association for the Study of Obesity (EASO) Research
Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity Policy, Research
Shaping Research with Patient Voices – Interview with ECO2025 Prize Winner Matthew Harris Shaping Research with Patient Voices – Interview with ECO2025 Prize Winner Matthew Harris ECN, ECN Spotlight, ECO, Research
Mapping Food Environments for Change – Interview with ECO2025 Prize Winner Chiara Gericke Mapping Food Environments for Change – Interview with ECO2025 Prize Winner Chiara Gericke ECN, ECN Spotlight, ECO, Research
Spotlight: Meet ECN Member Teona Nutsubidze Spotlight: Meet ECN Member Teona Nutsubidze ECN Spotlight
Early Career Network Spotlight: Meet Dr. Laurence Dobbie from the United Kingdom Early Career Network Spotlight: Meet Dr. Laurence Dobbie from the United Kingdom ECN Spotlight
EASO ECN Spotlight: meet Johanna Matilainen EASO ECN Spotlight: meet Johanna Matilainen ECN Spotlight
Introducing Paige Crompvoets, ECN Member from The Netherlands Introducing Paige Crompvoets, ECN Member from The Netherlands Early Career Network, ECN Spotlight, Member News
ECN Spotlight – Julia Mueller ECN Spotlight – Julia Mueller Early Career Network, ECN Spotlight, Education
Introducing EASO Early Career Network Member ‘Elwira Gliwska’ Introducing EASO Early Career Network Member ‘Elwira Gliwska’ Early Career Network, ECN Spotlight, Education, Member News
